Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring.
about
Factors Influencing Antiretroviral Adherence and Virological Outcomes in People Living with HIV in the Highlands of Papua New GuineaPoint of Care Technologies for HIVHIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assaysPerformance and logistical challenges of alternative HIV-1 virological monitoring options in a clinical setting of Harare, Zimbabwe.Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay.Systematic review of the performance of HIV viral load technologies on plasma samples.Low-cost assays for monitoring HIV infected individuals in resource-limited settings.Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam.Low-cost tools for diagnosing and monitoring HIV infection in low-resource settings.Can HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource-limited settings?The performance of reverse transcriptase assay for the estimation of the plasma viral load in HIV-1 and HIV-2 infections.Assessment of the Cavidi ExaVir Load Assay for Monitoring Plasma Viral Load in HIV-2-Infected Patients.Presence of HIV drug resistance in antiretroviral therapy-naive and -experienced patients from Papua New Guinea.Management of pregnancy in an HIV elite controller.
P2860
Q28547037-F6461018-E731-4913-BF6A-0D6E961149BBQ30442547-99128152-8204-4637-A09F-82996EBE1AFFQ33636945-341692CD-38A5-40C6-B26F-C5BF7E209CE2Q33849840-36E67907-B8A0-47F2-BD68-838C7FB82ED1Q34514881-0F2F094D-54DD-4346-969A-ABAACBD68474Q35099443-01A85429-31BB-4C5B-8C98-9CDA68985162Q35770858-04671E7E-081C-4A1B-AE20-92A4F22DD737Q36226907-2657C8C6-D09C-4F5B-BBA2-D65E833A86CDQ36474389-87D8E052-EEBD-497A-8A94-28FC661CCD98Q36526686-1DD70A09-34BC-44AD-805D-C9787D13B68EQ38384495-9FF67315-D153-4696-BC52-51B865FC9FC4Q40197811-F3704BD4-E573-4CE4-AECC-0CF332C85526Q42225318-1C586725-F8C4-4A07-A45F-5795151F317FQ46662416-F718BD37-7035-4107-A66D-4185EFB458B6
P2860
Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evaluation of the Cavidi ExaVi ...... virus type 1 load monitoring.
@en
Evaluation of the Cavidi ExaVir Load assay
@nl
type
label
Evaluation of the Cavidi ExaVi ...... virus type 1 load monitoring.
@en
Evaluation of the Cavidi ExaVir Load assay
@nl
prefLabel
Evaluation of the Cavidi ExaVi ...... virus type 1 load monitoring.
@en
Evaluation of the Cavidi ExaVir Load assay
@nl
P2093
P2860
P356
P1476
Evaluation of the Cavidi ExaVi ...... y virus type 1 load monitoring
@en
P2093
Anna Hearps
Lisa M Morris
Megan M Plate
Pauline M Steele
Suzanne M Crowe
Vicki L Greengrass
P2860
P304
P356
10.1128/JCM.00805-09
P407
P577
2009-07-15T00:00:00Z